Neuroprotective effect of recombinant human erythropoietin on optic nerve injury in rats
文献类型：期刊论文
| 作者 | Wang Hui; Liu Zheli; Zhuang Xiaotong; Wang Minfang; Xu Li |
| 刊名 | CHINESE MEDICAL JOURNAL
 |
| 出版日期 | 2009 |
| 卷号 | 122期号:17页码:2008-2012 |
| 关键词 | RETINAL GANGLION-CELLS MICE OVEREXPRESSING ERYTHROPOIETIN AXONAL REGENERATION EVOKED-POTENTIALS ADULT-RATS AXOTOMY DEGENERATION ASSOCIATION SYSTEM erythropoietin optic nerve injuries retinal ganglion cells growth associated protein 43 |
| ISSN号 | 0366-6999 |
| 其他题名 | Neuroprotective effect of recombinant human erythropoietin on optic nerve injury in rats |
| 英文摘要 | Background Optic nerve injury, caused by retinal and optic nerve diseases, can eventually result in vision loss. To date, few effective treatments have been discovered to restore visual function. Previous studies showed that recombinant human erythropoietin (rhEPO) has a neuroprotective effect on the central nervous system, particularly in nerve injury. In this study, we investigated the effects of rhEPO on axonal regeneration and functional restoration following optic nerve injury. This was done by measuring the expression of growth associated protein 43 (GAP-43), a marker for neuronal regeneration, on the retina and flash-visual evoked potential (F-VEP). |
| 语种 | 英语 |
| CSCD记录号 | CSCD:3681707 |
| 源URL | [http://ir.imr.ac.cn/handle/321006/150914]  |
| 专题 | 金属研究所_中国科学院金属研究所 |
| 作者单位 | 中国科学院金属研究所 |
| 推荐引用方式 GB/T 7714 | Wang Hui,Liu Zheli,Zhuang Xiaotong,et al. Neuroprotective effect of recombinant human erythropoietin on optic nerve injury in rats[J]. CHINESE MEDICAL JOURNAL,2009,122(17):2008-2012. |
| APA | Wang Hui,Liu Zheli,Zhuang Xiaotong,Wang Minfang,&Xu Li.(2009).Neuroprotective effect of recombinant human erythropoietin on optic nerve injury in rats.CHINESE MEDICAL JOURNAL,122(17),2008-2012. |
| MLA | Wang Hui,et al."Neuroprotective effect of recombinant human erythropoietin on optic nerve injury in rats".CHINESE MEDICAL JOURNAL 122.17(2009):2008-2012. |
入库方式： OAI收割
来源：金属研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。